{"id":"W2922462803","doi":"10.1186/s13195-019-0467-2","title":"Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer’s disease","year":2019,"lang":"en","type":"article","venue":"Alzheimer s Research & Therapy","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Cilag; Merck Sharp and Dohme; Novartis Pharma; Merz Pharmaceuticals; AstraZeneca; Eli Lilly and Company; Boehringer Ingelheim","keywords":"Tolerability; Medicine; Clinical Dementia Rating; Internal medicine; Clinical endpoint; Adverse effect; Placebo; Dementia; Clinical trial; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007486761,0.003209165,0.00593394,0.0008631093,0.0007428214,0.001397775,0.001769744,0.003225964,0.00652178],"category_scores_gemma":[0.005603749,0.001748171,0.002993,0.0009856133,0.002326338,0.002222572,0.0008364732,0.004064013,0.001232843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001154621,"about_ca_system_score_gemma":0.001897235,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006899929,"about_ca_topic_score_gemma":0.00149744,"domain_scores_codex":[0.9967878,0.001905288,0.0003134138,0.0004715771,0.0002043367,0.0003175319],"domain_scores_gemma":[0.9963516,0.001071984,0.0008663335,0.000421962,0.0003607754,0.0009274302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9653274,0.01541421,0.0003970828,0.0004436627,0.0005562347,0.00003872976,0.00009535887,0.0001972694,0.006971972,0.00004636596,0.0002279713,0.01028379],"study_design_scores_gemma":[0.7706141,0.226292,0.001432297,0.00001627499,0.0003762028,0.00002899514,0.00001926033,0.0001289254,0.0006217793,0.00005143564,0.0004006804,0.0000179574],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819702,0.004830928,0.001388017,0.0005391614,0.0004575903,0.008388036,0.001124276,0.0001300566,0.001171669],"genre_scores_gemma":[0.9644703,0.003696996,0.005545188,0.001046383,0.0006244956,0.01974419,0.001962193,0.00005372295,0.002856535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007486761,"threshold_uncertainty_score":0.03959423,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1071811292687882,"score_gpt":0.4065201067674525,"score_spread":0.2993389774986643,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}